Skip to main content

Want a detailed portfolio tracker?

CheckCap (MBAI) EBITDA (2013 - 2025)

CheckCap (MBAI) EBITDA from Dec 31, 2013 to Dec 31, 2025. The TTM CheckCap (MBAI) EBITDA is -$2.37M. You can adjust inflation or export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

Annual EBITDA

CheckCap (MBAI) EBITDA CAGR table

PeriodCAGR
1 Year-74.52%
3 Years-50.58%
5 Years-29.68%
10 Years-15.23%
All Time-4.05%

Annual EBITDA change of CheckCap (MBAI)

YearEBITDAChange
2025-$2.37M-74.52%
2024-$9.30M-51.23%
2023-$19M-2.85%
2022-$20M+14.66%
2021-$17M+24.24%
2020-$14M-1.22%
2019-$14M+27.75%
2018-$11M+10.98%
2017-$9.84M+10.19%
2016-$8.93M-27.81%
2015-$12M+177.35%
2014-$4.46M+14.65%
2013-$3.89MN/A

Comparison CheckCap (MBAI) five years EBITDA CAGR with competitors

CheckCap (MBAI) five years EBITDA CAGR is -29.66%.

TickerNamefive years EBITDA CAGRUpside
PRPHProPhase Labs Inc73.15%-346.61%
MEDPMedpace Holdings Inc25.16%-184.82%
ISPCiSpecimen Inc25.14%-184.75%
PSNLPersonalis Inc18.83%-163.47%
WATWaters Corp17.45%-158.84%
BNRBurning Rock Biotech Ltd17.26%-158.19%
ICLRIcon Plc12.53%-142.25%
IDXXIdexx Laboratories Inc11.66%-139.32%
CSTLCastle Biosciences Inc10.29%-134.68%
MTDMettler-Toledo International Inc9.87%-133.27%
MYNZMainz Biomed N.V.9.82%-133.11%
IQVIQVIA Holdings Inc9.14%-130.82%
RDNTRadnet Inc8.38%-128.27%
IMDXInsight Molecular Diagnostics Inc7.62%-125.67%
AAgilent Technologies Inc6.59%-122.21%
ILMNIllumina Inc5.98%-120.17%
GHGuardant Health Inc5.67%-119.12%
NTRANatera Inc3.35%-111.30%
TWSTTwist Bioscience Corp2.84%-109.57%
BDSXBiodesix Inc2.43%-108.21%
SHCSotera Health Company2.32%-107.83%
QGENQiagen NV2.21%-107.43%